These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 8370605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
    Pljesa S.
    Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722
    [Abstract] [Full Text] [Related]

  • 8. Low-dose subcutaneous erythropoietin in continuous ambulatory peritoneal dialysis.
    Rotellar C, Mazzoni MJ, Mosher WF, Aminrazavi M, Bauer A, Rakowski TA, Schreiner GE, Winchester JF.
    Am J Hematol; 1991 May; 37(1):31-3. PubMed ID: 2024637
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A, Di Liberato L, Daniele F, Battistel V, Colombi L.
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [Abstract] [Full Text] [Related]

  • 11. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN, Lui SF, Leung JC, Law E, Nicholls MG.
    Nephron; 1991 Jan; 57(4):394-400. PubMed ID: 1828543
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M, Roszkowska-Blaim M.
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [Abstract] [Full Text] [Related]

  • 13. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Oct; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 14. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Di Paolo B, Marini A, Fiederling B, Di Liberato L, Santarelli P, Bucciarelli S, Stuard S, Paolantonio L, Albertazzi A.
    Perit Dial Int; 1993 Oct; 13 Suppl 2():S538-40. PubMed ID: 8399659
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC, Lai YH, Tsai ZY, Chien LJ, Tsai JH.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

  • 17. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Jan; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 18. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M, Boguszewska-Baczkowska A, Jelonek A.
    Pol Tyg Lek; 1990 Jan; 49(6-7):135-6. PubMed ID: 8090665
    [Abstract] [Full Text] [Related]

  • 19. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG, Fischer ER, Harris DC.
    Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
    [Abstract] [Full Text] [Related]

  • 20. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
    Nesić V, Ostrić V, Kovacević Z, Dimković N, Curić S, Lazarević M, Ratković M, Bogdanović J, Jelacić R.
    Med Pregl; 2005 Nov; 58(5-6):279-85. PubMed ID: 16526235
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.